Four european countries including Denmark, The Netherlands, Portugal and Poland. Phase 1: 400 patients 120 nurses 100 patients and 30 nurses per country. Phase 2: 400 in-hospital patients, up to 200 home-monitored patients, up to 150 patients and 30 nurses per country
Study sites
Rigshospitalet, Bispebjerg Hospital, University Medical Centre Groningen, The Netherlands, NOVA Medical School, Portugal and Jagiellonian University Medical College, Poland
Inclusion criteria
Adults aged 18 years or older
Admitted with a medical or surgical condition
Expected hospital stay of at least two days
Study procedures
Informed consent
Observational data collection
Pre- and post-implementation questionnaires for patients and healthcare professionals
Patients wear clinical monitoring sensors
Nurses use WARD-CSS device/app for continuous vital-sign monitoring
Clinical outcomes and healthcare resource use are recorded
Follow-up up to 30 days after admission
Outcome
Phase 1:
Primary outcome: Map current monitoring practices
Secondary outcome: Patient experience
Phase 2:
Primary outcomes: Implementation potential and usability
Secondary outcomes: Adoption factors, data feasibility, complications ≤30 days